Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study

BACKGROUND: Dehydroepiandrosterone (DHEA) is now widely used as an adjuvant for in vitro fertilization (IVF) cycles in poor ovarian responders (PORs). Several studies showed that DHEA supplementation could improve IVF outcomes of PORs. However, most of the PORs do not respond to DHEA clinically. The...

Full description

Saved in:
Bibliographic Details
Published in:Reprod Biol Endocrinol
Main Authors: Chern, Chyi-Uei, Tsui, Kuan-Hao, Vitale, Salvatore Giovanni, Chen, San-Nung, Wang, Peng-Hui, Cianci, Antonio, Tsai, Hsiao-Wen, Wen, Zhi-Hong, Lin, Li-Te
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142344/
https://ncbi.nlm.nih.gov/pubmed/30223902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12958-018-0409-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items